Australia markets open in 9 minutes

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.0201-0.0099 (-0.25%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate-0.38-0.25-2.420.24
Low estimate-0.38-0.25-2.420.24
High estimate-0.38-0.25-2.420.24
Year ago EPS-6.12-7.08-27.96-2.42
Revenue estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate3.36M3.74M11.38M20M
Low estimate3.36M3.74M11.38M20M
High estimate3.36M3.74M11.38M20M
Year ago sales1.56M1.68M5.18M11.38M
Sales growth (year/est)115.00%123.20%119.60%75.70%
Earnings history29/09/202330/12/202330/03/202429/06/2024
Est. EPS-7.44-6-2.52-0.72
Actual EPS-6.12-7.08-2.04-0.93
Difference1.32-1.080.48-0.21
Surprise %17.70%-18.00%19.00%-29.20%
EPS trendCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Current estimate-0.38-0.25-2.420.24
7 days ago-0.38-0.25-2.420.24
30 days ago0.120.48-0.961.2
60 days ago0.010.04-0.080.1
90 days ago0.010.04-0.080.1
EPS revisionsCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesEVOKIndustrySector(s)S&P 500
Current qtr.93.80%N/AN/AN/A
Next qtr.96.50%N/AN/AN/A
Current year91.30%N/AN/AN/A
Next year109.90%N/AN/AN/A
Next 5 years (per annum)40.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A